Plus Therapeutics, Inc. (PSTV) DCF Valuation

Plus Therapeutics, Inc. (PSTV) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Plus Therapeutics, Inc. (PSTV) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Discover the true potential of Plus Therapeutics, Inc. (PSTV) with our advanced DCF Calculator! Adjust key assumptions, explore various scenarios, and assess how modifications influence the valuation of Plus Therapeutics, Inc. (PSTV) – all within a comprehensive Excel template.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 7.0 .3 .0 .2 4.9 3.7 2.8 2.2 1.6 1.3
Revenue Growth, % 0 -95.67 -100 0 2093.3 -23.92 -23.92 -23.92 -23.92 -23.92
EBITDA -1.0 -6.8 -12.5 -18.9 -12.7 -1.6 -1.2 -.9 -.7 -.5
EBITDA, % -14.1 -2232.67 100 -8416.07 -258.36 -42.82 -42.82 -42.82 -42.82 -42.82
Depreciation .4 .4 .4 .7 .6 2.4 1.8 1.4 1.1 .8
Depreciation, % 6.3 121.78 100 317.86 12.78 63.82 63.82 63.82 63.82 63.82
EBIT -1.4 -7.1 -12.9 -19.6 -13.3 -1.6 -1.3 -1.0 -.7 -.6
EBIT, % -20.41 -2354.46 100 -8733.93 -271.14 -44.08 -44.08 -44.08 -44.08 -44.08
Total Cash 17.6 8.3 18.4 18.1 8.6 3.7 2.8 2.2 1.6 1.3
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1.2 .1 .0 .0 .0
Account Receivables, % 16.7 19.47 100 0 0
Inventories .1 -.1 .0 .0 .0 .6 .5 .4 .3 .2
Inventories, % 1.53 -19.47 100 0 0 16.41 16.41 16.41 16.41 16.41
Accounts Payable .3 .8 2.6 8.4 4.8 3.0 2.3 1.7 1.3 1.0
Accounts Payable, % 4.67 260.4 100 3733.93 96.85 80.3 80.3 80.3 80.3 80.3
Capital Expenditure -.1 -.5 -.1 -.5 -.2 -1.5 -1.2 -.9 -.7 -.5
Capital Expenditure, % -0.95742 -162.71 100 -227.23 -3.26 -40.84 -40.84 -40.84 -40.84 -40.84
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -5.5 -8.1 -13.8 -20.1 -13.3 -1.6 -1.3 -1.0 -.7 -.6
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -6.1 -6.5 -11.7 -14.2 -16.5 -4.2 -.9 -.7 -.5 -.4
WACC, % 8.64 8.64 8.64 8.64 8.64 8.64 8.64 8.64 8.64 8.64
PV UFCF
SUM PV UFCF -5.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value -6
Present Terminal Value -4
Enterprise Value -10
Net Debt -4
Equity Value -6
Diluted Shares Outstanding, MM 3
Equity Value Per Share -1.79

What You Will Receive

  • Comprehensive Financial Model: Plus Therapeutics' actual data facilitates accurate DCF valuation.
  • Complete Forecast Control: Modify revenue growth, profit margins, WACC, and other critical factors.
  • Real-Time Calculations: Instant updates allow you to view results as adjustments are made.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation.
  • Flexible and Reusable: Designed for adaptability, enabling repeated use for in-depth forecasts.

Key Features

  • Customizable Treatment Parameters: Adjust essential factors such as dosing regimens, patient demographics, and clinical endpoints.
  • Real-Time Data Analysis: Provides instant insights into trial outcomes, patient responses, and statistical significance.
  • High-Precision Modeling: Utilizes Plus Therapeutics, Inc.'s (PSTV) proprietary data for accurate therapeutic evaluations.
  • Effortless Scenario Testing: Easily explore various treatment scenarios and their potential impacts.
  • Efficiency Booster: Streamlines the process of developing complex clinical trial models without starting from scratch.

How It Works

  1. Step 1: Download the Excel file for Plus Therapeutics, Inc. (PSTV).
  2. Step 2: Review the pre-filled financial data and projections for Plus Therapeutics.
  3. Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
  5. Step 5: Evaluate the outputs and leverage the results for your investment strategies.

Why Choose Plus Therapeutics Calculator?

  • Accuracy: Utilizes real Plus Therapeutics financial data to ensure precision.
  • Flexibility: Allows users to easily test and adjust inputs as needed.
  • Time-Saving: Eliminate the complexity of creating a financial model from the ground up.
  • Professional-Grade: Crafted with the expertise and usability expected at the CFO level.
  • User-Friendly: Intuitive interface designed for users of all financial backgrounds.

Who Should Use Plus Therapeutics, Inc. (PSTV)?

  • Investors: Gain insights into innovative therapies and make informed investment choices.
  • Healthcare Analysts: Utilize comprehensive data to evaluate market potential and therapeutic efficacy.
  • Consultants: Tailor the information for client briefings or strategic planning sessions.
  • Biotech Enthusiasts: Explore cutting-edge developments in the biotech field through real-world case studies.
  • Educators and Students: Leverage the resources for practical applications in biotechnology and pharmaceutical courses.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Plus Therapeutics, Inc. (PSTV) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Plus Therapeutics, Inc. (PSTV).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.